Large Molecule Bioanalytical Testing Services Market Oncology Segment Is Projected To Witness The Fastest CAGR Of 10.1 %

 Large Molecule Bioanalytical Testing Services Industry Overview

The global large molecule bioanalytical testing services market size was valued at USD 1.4 billion in 2020 and is expected to witness a compound annual growth rate (CAGR) of 9.5% from 2021 to 2028. An increase in demand for advanced and quality large molecule bioanalytical testing services and the rising complexity of product designs and engineering are factors anticipated to boost the market growth. Rapid innovations in healthcare have increased the need for pharmaceutical companies to adopt new technologies in their services, to maintain market demand. Less time to market, increase in regulatory oversight, and high risk of product failure are some factors increasing the need for large molecule bioanalytical testing services. The nature of COVID-19 transmission has led several laboratory staff to face uncertainties, such as fears of contracting the infection along with other biosafety concerns. Thus, reduced manpower and increasing focus on the development of vaccines & therapies against COVID-19 are anticipated to negatively impact the turnaround time for routine tests. In multiple countries, bioanalytical laboratories are a part of the essential healthcare infrastructure, thus bioanalytical studies were continued with minimal or no initial disruptions. Some of the initial disruptions were increased workload on CROs due to reduced internal lab testing capacities of several biopharmaceutical firms, suspension of courier services, and IT disturbances.

Gather more insights about the market drivers, restrains and growth of the Global Large Molecule Bioanalytical Testing Services market

 

The demand for quality healthcare is increasing due to increasing healthcare costs. With growing innovations pertaining to new pharmaceutical products, the demand for analytical testing is increasing. Many companies are opting for outsourcing services for analytical testing owing to increasing competition in the healthcare industry and growing pricing concerns. Technological advancements and focus on customized care shorten a product’s life cycle, which leads to the rapid development of new products. Increasing R&D activities for new drug development, combination products, and other advanced medicines have increased the demand for analytical testing. Cost is also another factor boosting the demand for analytical testing. Almost all biopharmaceutical companies outsource some of their services, such as analytical testing, to be able to focus on their core competencies and largely reduce in-house repetitive tasks or complex activities. Outsourcing offers cost savings as companies do not have to establish specialized facilities or hire more staff. Analytical testing is one of the top areas of outsourcing for bio-manufacturers globally, with 90.4% of companies outsourcing this activity. It is outsourced due to the need for highly specialized staff to run assays and maintain equipment.


Browse through Grand View Research's Biotechnology Industry Research Reports.

  • Tissue Sectioning Market - The global tissue sectioning market size was worth USD 518.58 million in 2019 and is projected to register a CAGR of 6.56% over the forecast period. Rising prevalence of chronic diseases and cancers is one of the crucial factors driving demand for histopathology tests as a tissue pathology examination is of utmost importance for the diagnosis of a malignant tumor.

 

  • Protein Stability Analysis Market - The global protein stability analysis market size was valued at USD 985.8 million in 2019 and is expected to register a CAGR of 10.8% over the forecast period. Protein stability analysis is a crucial step during drug development, right from active pharmaceutical ingredient (API) development up to product validation. Key players are engaged in implementing these testing techniques for assessment of the quality and effectiveness of drug products under various environmental factors.

 

Large Molecule Bioanalytical Testing Services Market Segmentation

Grand View Research has segmented the global large molecule bioanalytical testing services market based on phase, type, test type, therapeutic area, end-user, and region:

Large Molecule Bioanalytical Testing Services Phase Outlook (Revenue, USD Million, 2016 - 2028)

  • Preclinical
  • Clinical

 

Large Molecule Bioanalytical Testing Services Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Pharmacokinetics
  • ADA
  • Others

 

Large Molecule Bioanalytical Testing Services Test Type Outlook (Revenue, USD Million, 2016 - 2028)

  • ADME
  • PK
  • PD
  • Bioavailability
  • Bioequivalence
  • Other Tests

 

Large Molecule Bioanalytical Testing Services Therapeutic Area Outlook (Revenue, USD Million, 2016 - 2028)

  • Oncology
  • Infectious Diseases
  • Cardiology
  • Neurology
  • Others

Large Molecule Bioanalytical Testing Services End-user Outlook (Revenue, USD Million, 2016 - 2028)

  • SMEs
  • Large Firms

 

Large Molecule Bioanalytical Testing Services Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

 

Key Companies profiled:

Some prominent players in the global Large Molecule Bioanalytical Testing Services market include

  • Covance, Inc.
  • IQVIA
  • Syneos Health
  • SGS SA
  • Toxikon
  • Intertek Group plc
  • Pace Analytical Services LLC
  • PPD, INC.
  • ICON plc
  • Charles River Laboratories International

 

Order a free sample PDF of the Large Molecule Bioanalytical Testing Services Market Intelligence Study, published by Grand View Research.

 

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

 

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Comments

Post a Comment

Popular posts from this blog

Behavioral Health Care Software And Services Market Growth Opportunity, Competitive Landscape and Forecast to 2030

  Behavioral Health Care Software And Services Market pr1   Behavioral Health Care Software And Services Industry Overview The global behavioral health care software and services market size was valued at USD 2.9 billion in 2021 and is expected to expand at a CAGR of 12.78% during the forecast period. Government funding, increasing adoption of mental health software, favorable behavioral health reforms in the United States, government initiatives to promote EHR adoption in psychiatry hospitals and facilities, and high demand for mental health services despite provider shortages are major factors contributing to the market growth. The adoption of management software by healthcare providers is likely to improve the treatment of mental wellbeing issues. Also, the adoption of integrated EHRs can help behavioral health practices in effective practice management and cost-saving. Tele-mental health involves coordinating with patients at distant locations via video conferencing. T...
Read more

What Will Be The Post-Pandemic Scenario Of The Magnetic resonance imaging Market?

  Magnetic Resonance Imaging Industry Overview The global magnetic resonance imaging market size was valued at USD 5.3 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.0% from 2021 to 2028. Magnetic resonance imaging (MRI) is an efficient diagnostic machine for identifying diseases related to spine lesions, tumors, and stroke impacting the area of blood vessels and brain. The increasing prevalence of these diseases is expected to play an important role in market growth. For instance, as per the American Cancer Society, in 2019, 1,762,450 new cancer cases were recorded in the U.S. In addition to this, the growing demand for quick and effective diagnostic procedures is expected to contribute towards the adoption of MRI machines. Various countries are installing these MRI machines. For instance, as per OECD, in 2017 the number of MRI units installed in the U.S. was 37.6 per million population. Advancements in diagnostic techniques such as open M...
Read more